RIVOLTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 8.626
EU - Europa 4.124
AS - Asia 1.129
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 16
AF - Africa 10
OC - Oceania 5
Totale 13.927
Nazione #
US - Stati Uniti d'America 8.449
IT - Italia 919
DE - Germania 912
CN - Cina 642
SE - Svezia 577
IE - Irlanda 523
UA - Ucraina 318
GB - Regno Unito 250
HK - Hong Kong 186
CA - Canada 174
AT - Austria 129
VN - Vietnam 119
DK - Danimarca 101
FI - Finlandia 101
FR - Francia 73
RU - Federazione Russa 68
IN - India 66
BE - Belgio 40
TR - Turchia 35
PL - Polonia 30
ES - Italia 17
NL - Olanda 16
IR - Iran 15
EU - Europa 14
RO - Romania 14
BG - Bulgaria 13
JP - Giappone 11
SG - Singapore 10
BR - Brasile 9
CH - Svizzera 9
IQ - Iraq 9
GE - Georgia 6
KR - Corea 6
PK - Pakistan 6
CX - Isole del Natale 5
SC - Seychelles 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
AU - Australia 3
MX - Messico 3
NG - Nigeria 3
BD - Bangladesh 2
BY - Bielorussia 2
CL - Cile 2
GR - Grecia 2
ID - Indonesia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
KH - Cambogia 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 13.927
Città #
Ann Arbor 2.122
Woodbridge 885
Frankfurt am Main 761
Chandler 734
Fairfield 722
Wilmington 519
Dublin 510
Houston 470
Ashburn 406
Jacksonville 334
Dearborn 310
Milan 309
Seattle 257
New York 226
Cambridge 214
Princeton 198
Hong Kong 186
Nanjing 141
Vienna 126
Lawrence 79
Shanghai 79
Altamura 69
Beijing 62
Rome 58
Toronto 57
Lachine 54
San Diego 48
Dong Ket 46
Guangzhou 45
Nanchang 44
Helsinki 41
Fremont 39
Boardman 37
Brussels 37
Andover 35
Ottawa 35
Shenyang 29
Kraków 27
Falls Church 25
Tianjin 24
Pune 22
Jinan 21
London 20
Norwalk 20
Hebei 19
Zhengzhou 19
Changsha 18
Edmonton 18
Los Angeles 18
Jiaxing 15
Kiev 14
Kunming 14
Ningbo 14
Taizhou 14
Washington 14
Plovdiv 12
Bari 11
Brugherio 11
Hefei 11
Monza 11
Mountain View 11
Bergamo 9
Bologna 9
Bonndorf 9
Hangzhou 9
Lecco 9
Sesto San Giovanni 9
Como 8
Lanzhou 8
Leawood 8
Verona 8
Huizen 7
Nürnberg 7
Redmond 7
San Mateo 7
Turin 7
Angers 6
Dalmine 6
Delhi 6
Grumo Nevano 6
Orange 6
Segrate 6
Alba 5
Ardabil 5
Auburn Hills 5
Buffalo 5
Chennai 5
Chicago 5
Dallas 5
Erba 5
Flying Fish Cove 5
Montréal 5
Pavia 5
Philadelphia 5
Sacramento 5
University Park 5
Xian 5
Augusta 4
Brescia 4
Cesano Maderno 4
Totale 10.971
Nome #
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 326
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 289
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 271
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 268
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes 256
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 256
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 241
Respiratory Mechanics and Fluid Dynamics After Lung Resection Surgery 237
Hypoxia-induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells 228
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 223
Interstitial pressure and lung oedema in chronic hypoxia 219
Effect of the ketogenic diet in excitable tissues 219
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 218
From morphological heterogeneity at alveolar level to the overall mechanical lung behavior: an in vivo microscopic imaging study 216
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 211
Binary biocompatible CNCs-Gelatine hydrogel as 3D scaffolds suitable for cell culture adhesion and growth 209
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 208
Cardiopulmonary Consequences of Post Thoracic Surgery Pulmonary Hypertension: Cause or Consequence of Lung Edema? 192
Hepcidin regulation in a mouse model of acute hypoxia 192
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 192
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 191
Brugada syndrome genetics is associated with phenotype severity 187
Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema 185
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype 185
Dynamic Investigation of Interaction of Biocompatible Iron Oxide Nanoparticles with Epithelial Cells for Biomedical Applications 180
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 180
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 180
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 178
Cardiac and neuronal HCN channelopathies 178
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 175
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination 173
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? 173
SCN4A as modifier gene in patients with myotonic dystrophy type 2 172
Oxygen-loaded nanodroplets effectively abrogate hypoxia dysregulating effects on secretion of MMP-9 and TIMP-1 by human monocytes 166
Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes 162
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 161
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 161
Identification and functional characterisation of a new KCNJ2 mutation 158
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes 157
Vander Fisiologia 157
Remodelling of Membrane Rafts Expression in Lung Cells as an Early Sign of Mechanotransduction-Signalling in Pulmonary Edema 156
An outlook on the potential of Si nanocrystals as luminescent probes for bioimaging 151
Role of the Air-Blood Barrier Phenotype in Lung Oxygen Uptake and Control of Extravascular Water 149
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020) 148
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues 145
Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths 143
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter 142
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia 142
Genetics of Long QT, Brugada, and Other Channelopathies 142
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death 142
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome 140
Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons 140
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 138
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 134
Gold Branched Nanoparticles for Cellular Treatments 132
Computer simulation of wild-type and mutant human cardiac Na+ current 129
Experimental model to evaluate the effect of hydrothorax and lobar resection on lung compliance 127
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene 126
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 126
Ion Channel as Target for Drugs 125
HCN1 novel mutations in familiar generalized epilepsy 125
Silica encapsulation of luminescent silicon nanoparticles: Stable and biocompatible nanohybrids 124
‘In Vitro’, ‘In Vivo’ and ‘In Silico’ Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector 124
Acetylation mediates Cx43 reduction caused by electrical stimulation 123
Alveolar mechanics studied by in vivo microscopy imaging through intact pleural space 121
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 117
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles 115
Invitro- Invivo fluctuation spectroscopies 115
Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: New insights for chronic wound healing 114
Regional Differences in the protein patterns related to lung remodeling and oxygen sensing 112
The effect of exogenous surfactant on alveolar interdependence 111
Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium 110
Ion channels in the heart 108
Bio-medical and sensor application of silicon nanoparticles 104
Cardiac sodium channel diseases 100
SCN4A as modifier gene in myotonic dystrophy type 2 (DM2) patients with early and severe myotonia 97
Comparative expression of two oxygen-dependent transcription factors (O2TF) in lungs, heart and skeletal muscles in a rat model of chronic hypoxia (CH) 95
Markovian model for wild-type and mutant (Y1795C and Y1795H) human cardiac Na/sup +/ channel 94
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel 93
Vander Fisiologia 93
Cellular interaction with Si- and Iron-based nanoparticles for bio-imaging. A study of biocompatibility (Conference Paper ) 92
In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes 91
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 90
A rabbit model of uremia-induced cardiomyopathy 89
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 88
Advances in the preparation of novel functionalized nanoparticles for bioimaging 85
Mechanistic considerations on the development of lung edema: Vascular, perivascular and molecular aspects from early stage to tissue and vascular remodeling stage 84
Inherited Brugada and Long QT-3 Syndrome Mutations of a Single Residue of the Cardiac Sodium Channel Confer Distinct Channel and Clinical Phenotypes 82
Fisiologia Medica - Terza Edizione 81
Stimulation of protein kinase C inhibits bursting in disease-linked mutant human cardiac sodium channels 80
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation 76
A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction 75
Characterization of sodium channel alpha- and beta-subunits in rat and mouse cardiac myocytes 75
Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation 72
The S5 segment of domain D3 of the cardiac sodium channel controls the kinetic of inactivation: Clues from inherited diseases 68
Nav1.5 channels are regulated by the ubiquitin ligase Nedd4-2 60
Functional studies of a novel copy number deletion in GSTM3 gene associated with increase of ventricular arrhythmia in patients with Brugada syndrome and ICD implantation 58
Sangue 51
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 48
Alterations of the Sialylation Machinery in Brugada Syndrome 44
Totale 14.591
Categoria #
all - tutte 39.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019658 0 0 0 0 0 0 0 0 0 165 203 290
2019/20202.702 270 136 174 202 251 305 399 186 256 167 281 75
2020/20212.569 156 135 329 270 172 211 254 195 197 226 168 256
2021/20221.589 143 180 164 153 72 120 95 78 63 112 123 286
2022/20232.945 321 865 342 302 208 431 24 133 191 25 55 48
2023/20241.603 56 64 84 127 232 473 337 52 137 41 0 0
Totale 14.794